Gold Nanoparticles for Drug Delivery
- 1st Edition - November 29, 2023
- Editor: Prashant Kesharwani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 9 0 6 1 - 2
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 9 0 6 2 - 9
Gold Nanoparticles for Drug Delivery discusses the synthesis and characterization of gold nanoparticles (AuNPs), presenting an historical introduction to the developments in the ar… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteGold Nanoparticles for Drug Delivery discusses the synthesis and characterization of gold nanoparticles (AuNPs), presenting an historical introduction to the developments in the area, discussing methods and characterization parameters, covering targeted delivery strategies, treatment of cancer, CNS conditions, infectious diseases, HIV/AIDS infection, wound healing and tissue regeneration, dentistry, gene delivery, and its photo properties used in diagnostic and therapies, and finally presenting regulatory aspects such as theranostic applications, vaccine development, toxicity, and the translation of research to marketable products.
This book is a complete reference for researchers in nanotechnology drug delivery and pharmaceutical disciplines. Researchers in pharmaceutical industries, especially those involved in the use of gold nanoparticles in the field of drug delivery, diagnosis, targeted and early therapies will also benefit from this book.
- Covers gold nanoparticles' characterization and synthesis techniques related to drug delivery
- Focuses on targeting strategies using gold nanoparticles for efficient drug delivery
- Provides a consolidated overview of applications of gold nanoparticles for drug delivery to several systems and conditions
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of contributors
- About the editor
- Preface
- Acknowledgments
- Part A: Synthesis and characterization of gold nanoparticles for drug delivery
- Chapter 1. History, introduction, and physiochemical properties of gold nanoparticles
- Abstract
- 1.1 History of development of gold nanoparticles
- 1.2 Introduction
- 1.3 Various types of nanoparticles
- 1.4 Synthesis of various types of gold nanoparticle
- 1.5 Physicochemical properties of gold nanoparticles
- 1.6 Conclusion
- References
- Chapter 2. Green synthesis and characterization parameters of gold nanoparticles
- Abstract
- 2.1 Introduction
- 2.2 Green synthesis of AuNPs
- 2.3 Characterization of AuNPs
- 2.4 Conclusions and future prospects
- Acknowledgements
- References
- Chapter 3. Cellular interactions and design principles of glyco-gold nanoparticles for drug delivery applications
- Abstract
- 3.1 Introduction
- 3.2 Synthesis methodologies of GAuNPs
- 3.3 Design principles of GAuNPs
- 3.4 Development of GAuNPs for drug delivery applications
- 3.5 Concluding remarks
- References
- Part B: Application of gold nanoparticles in drug delivery
- Chapter 4. Targeting strategies using gold nanoparticles for efficient drug delivery
- Abstract
- 4.1 Introduction
- 4.2 Passive targeting
- 4.3 Active targeting
- 4.4 Magnetic iron oxide cores
- 4.5 Small molecules
- 4.6 Peptides and proteins
- 4.7 DNA and RNA
- 4.8 Conclusions
- References
- Chapter 5. Gold nanoparticles for delivery of nucleic acid constructs for cancer treatment
- Abstract
- 5.1 Introduction
- 5.2 Delivery of RNA using AuNP constructs for cancer therapy
- 5.3 DNA delivery via AuNP constructs
- 5.4 Conclusion and future prospects
- References
- Chapter 6. Theranostic gold nanoparticle-assisted tumor radiosensitization and imaging
- Abstract
- 6.1 Introduction
- 6.2 Gold nanoparticle-assisted radiation therapy
- 6.3 Gold nanoparticle-based molecular imaging: X-ray fluorescence imaging
- 6.4 Conclusion
- Acknowledgement
- References
- Chapter 7. Potential therapeutic role of gold nanoparticles in inflammatory diseases
- Abstract
- 7.1 Introduction
- 7.2 Gold nanoparticles
- 7.3 Inflammation
- 7.4 Gold nanoparticles in the treatment of inflammatory diseases
- References
- Chapter 8. The use of gold nanoparticles in the treatment of neurodegenerative diseases
- Abstract
- 8.1 Introduction
- 8.2 Parkinson’s disease
- 8.3 Alzheimer’s disease
- 8.4 Duchenne muscular dystrophy
- 8.5 Multiple sclerosis
- References
- Chapter 9. Gold nanoparticles for treatment of cerebral diseases
- Abstract
- 9.1 Introduction
- 9.2 Blood-brain barrier
- 9.3 Gold nanoparticle for treatment of cerebral diseases
- 9.4 Brian disease diagnosis
- 9.5 Outlook and conclusion
- Acknowledgment
- References
- Chapter 10. Gold nanoparticles for treatment of infectious diseases
- Abstract
- 10.1 Introduction
- 10.2 Bacterial infection
- 10.3 Viral infection
- 10.4 Fungal infection
- 10.5 Parasitic infection
- 10.6 Conclusion and future prospects
- Acknowledgments
- References
- Chapter 11. Gold nanoparticles as a recent nanocarrier against HIV/AIDS
- Abstract
- 11.1 Introduction
- 11.2 Definition of AuNPs
- 11.3 AuNP synthesis
- 11.4 AuNP application in biomedicine
- 11.5 Nanotechnology approaches for HIV/AIDS therapy
- 11.6 Inhibition of HIV by AuNPs
- 11.7 AuNPs to improve HIV drug delivery
- 11.8 Recent breakthroughs in AuNP technology
- 11.9 Conclusion and future perspective
- Acknowledgment
- References
- Chapter 12. Gold nanoparticles in tissue engineering and regeneration
- Abstract
- 12.1 Introduction
- 12.2 Tissue regeneration
- 12.3 Heart
- 12.4 Skin
- 12.5 Bone
- 12.6 Neural tissues
- 12.7 Chemical synthesis
- 12.8 Future perspectives
- 12.9 Challenges
- 12.10 Conclusion
- References
- Chapter 13. Applications of gold nanoparticle in regenerative medicine
- Abstract
- 13.1 Regenerative medicine and nanotechnology
- 13.2 Main characteristics of gold nanoparticle used in regenerative medicine
- 13.3 AuNP in regenerative medicine
- 13.4 Conclusion
- References
- Chapter 14. Gold nanoparticles in photodynamic and photothermal therapy
- Abstract
- 14.1 Introduction
- 14.2 Photo-induced therapy
- 14.3 Versatility of AuNPs as multifunction photoactive tools
- 14.4 Limitations
- References
- Chapter 15. Polymeric gold nanoparticles for gene therapy
- Abstract
- 15.1 Introduction
- 15.2 Gold nanoparticles synthesis
- 15.3 Characterization of gold nanoparticles
- 15.4 Role of ligand in nanoparticles stability
- 15.5 Surface functionalization of gold nanoparticles for gene delivery
- 15.6 Role of size and shapes of gold nanoparticles as nucleic acid delivery carrier
- 15.7 Stimuli-responsive gold nanoparticles in gene therapy
- 15.8 Gold nanoparticles-based theranostics
- 15.9 Conclusion and future perspective
- References
- Part C: Recent advances and regulatory aspects of gold nanoparticles
- Chapter 16. Hybrid gold nanoparticles as advanced drug delivery and theranostics application
- Abstract
- 16.1 Introduction
- 16.2 Hybrid AuNPs for drug delivery application
- 16.3 Hybrid AuNPs for theranostics application
- 16.4 Conclusion
- References
- Chapter 17. Application of gold nanoparticles in vaccine development
- Abstract
- 17.1 Introduction
- 17.2 Synthesis of AuNPs
- 17.3 The Turkevich method
- 17.4 The Frens method
- 17.5 The Brust method
- 17.6 Characterization of AuNPs
- 17.7 Spectrophotometry
- 17.8 Dynamic light scattering
- 17.9 Electron microscopy
- 17.10 Functionalization of AuNPs
- 17.11 Physisorption
- 17.12 Chemisorption
- 17.13 Vaccine studies using AuNPs
- 17.14 Model antigens
- 17.15 Viral antigens
- 17.16 Bacterial or parasitic antigens
- 17.17 Cancer antigens
- 17.18 Recent studies on the safety of AuNPs and ongoing clinical trials
- 17.19 Perspectives and conclusive remarks
- References
- Chapter 18. Clinical translation of gold nanoparticles: obstacles and perspectives
- Abstract
- 18.1 Introduction
- 18.2 Obstacles and failures
- 18.3 Standardization of research to enhance clinical translation
- 18.4 Concluding remark
- References
- Chapter 19. Conclusion and future perspective of gold nanoparticles
- Abstract
- 19.1 Introduction
- 19.2 AuNPs—an important tool to treat various diseases
- 19.3 Theranostic applications of AuNPs and associated toxicity
- 19.4 Synthesis and characterization parameters of AuNPs
- 19.5 Targeting and uptaking of AuNPs for drug delivery
- 19.6 Conclusion and future prospects of AuNPs
- Acknowledgement
- References
- Index
- No. of pages: 572
- Language: English
- Edition: 1
- Published: November 29, 2023
- Imprint: Academic Press
- Paperback ISBN: 9780443190612
- eBook ISBN: 9780443190629
PK
Prashant Kesharwani
Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.